Abbigale Ingram, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2416 Elizabeth Ln, Seagoville, TX 75159 Phone: 972-287-2491 |
News Archive
IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired Senior Care of Colorado, PC (SCOC) headquartered in Aurora, Colorado. SCOC provides geriatric care at more than 200 facilities in the Denver metro area. SCOC has an annualized volume of more than 200,000 patient encounters. This acquisition represents an expansion of operations for IPC in Colorado, where the company has provided acute care hospitalist services since 2003.
New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options.
Genomic Health, Inc. today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX® breast cancer Recurrence Score® (RS) result is a significant independent predictor of distant recurrence in both node-negative and node-positive, hormone receptor-positive, postmenopausal breast cancer patients who are treated with either anastrozole or tamoxifen.
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that it has achieved its first technology transfer milestone in connection with the company's recently announced exclusive stem cell agreement with Novartis, one of the world's largest healthcare companies. The milestone was completed on schedule and triggers a payment of $500,000 to Opexa.
Scientists at the VIB-UGent Center for Medical Biotechnology have taken important steps forward in the development of a cancer-targeting immunotherapy.
› Verified 1 days ago